Stimulant Use Disorder (May/June)

Date of Issue: 05/01/2021 | Volume: 9 | Number: 3

Issue Links:Learning Objectives | Editorial Information

How should we treat patients with stimulant use disorder? With promising treatments seemingly always just over the horizon, and still no FDA approved medications, providers can be left feeling lost. Here, we review the latest evidence with our expert Dr. de la Cruz. Also, a primer on loperamide misuse and an observational study on marijuana’s impact on quality of life.

In This Issue

New Editor-in-Chief

Welcoming Our New Editor-in-Chief

We’re pleased to introduce Noah Capurso, MD, MHS as the new editor-in-chief of The Carlat Addiction Treatment Report. Dr. Capurso is an assistant professor of psychiatry at the Yale University School of Medicine and practices clinically at the West Haven Veterans Administration Hospital.

Read More
Clinical Update

Pharmacotherapy for Stimulant Use Disorders

Topics: medications | Pharmacotherapy | Stimulants

There are no approved pharmacotherapies for stimulant use disorders. Lots of medications have been studied and the results have been mixed. Here we provide you with the latest data, and some treatment recommendations.

Read More
Expert Q&A

Diagnosing and Treating Stimulant Use Disorders

Topics: contingency management | Diagnosis | Harm reduction | online therapy | Pharmacotherapy | Psychotherapy | Stimulants

Dr. de la Cruz gives advice for working with patients with addiction to prescription and illicit stimulants. She provides concrete strategies for diagnosis, harm reduction, evidence-based treatments, and contingency management in this challenging patient population.

Read More
Clinical Update

An Unexpected Opioid: Loperamide Misuse

Topics: Opioids | Over the counter medication | safety | Side Effects

We normally think of loperamide as an over-the-counter drug with a good safety profile. And it is, but only when used as directed. Recreational misuse of loperamide is on the rise with some dangerous collateral effects.

Read More
Research Update

A Psychosocial Intervention for Chronic Pain and SUD

Topics: Clinical practice | Marijuana | observational study | Pain | quality of life

Does marijuana use reduce pain and improve quality of life over time? This observational, uncontrolled trial suggests it might, but also identifies the need for more rigorous future studies.

Read More
CME Post-Test

CME Post-Test - Stimulant Use Disorder, CATR, May/June 2021

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit.

Read More